EI
CVAC

Ellevest Inc’s CureVac CVAC Stock Holding History

Ellevest Inc’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-51
Closed -$1K – 1657
2022
Q2 		$1K Sell
51
-15
-23% -$248 ﹤0.01% 1234
2022
Q1 		$1K Buy
66
+12
+22% +$240 ﹤0.01% 1275
2021
Q4 		$2K Sell
54
-12
-18% -$483 ﹤0.01% 1149
2021
Q3 		$4K Buy
+66
New +$3.98K ﹤0.01% 996
2021
Q2 		– Sell
-260
Closed -$24K – 1293
2021
Q1 		$24K Hold
260
– – ﹤0.01% 619
2020
Q4 		$21K Buy
+260
New +$19.9K ﹤0.01% 621

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellevest Inc's CVAC Position: Q3 2022 in Review

Ellevest Inc sold out of CureVac (CVAC) in Q3 2022, closing a stake of 51 shares — an estimated $1K sold.

Ellevest Inc first reported a position in CVAC in Q4 2020 and held it in 6 quarters. The position peaked at $24K in Q1 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

  • Ellevest Inc reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 51 CureVac shares in Q3 2022, an estimated $1K.
  • Ellevest Inc first reported a position in CureVac in Q4 2020 and held it in 6 quarters.
  • Ellevest Inc's CureVac position peaked at $24K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.